Last reviewed · How we verify
Chlorhexidine sol 4%
At a glance
| Generic name | Chlorhexidine sol 4% |
|---|---|
| Also known as | Lifo-Scrub sol 4% |
| Sponsor | Lindenhofgruppe AG |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Preoperative Decolonization and Surgical Site Infections in Orthopaedic Surgery - 2 Year Outcome in Prosthetic Surgery (PHASE4)
- Preoperative Decolonization and Surgical Site Infections - a Prospective Randomized Trial (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Chlorhexidine sol 4% CI brief — competitive landscape report
- Chlorhexidine sol 4% updates RSS · CI watch RSS
- Lindenhofgruppe AG portfolio CI